Search Results - "Larocca, L."

School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18 by Dobbins, Maureen, Husson, Heather, DeCorby, Kara, LaRocca, Rebecca L

“…The World Health Organization (WHO) estimates that 1.9 million deaths worldwide are attributable to physical inactivity and at least 2.6 million deaths are a…”
Get more information

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study by Cabibbo, G., Petta, S., Calvaruso, V., Cacciola, I., Cannavò, M. R., Madonia, S., Distefano, M., Larocca, L., Prestileo, T., Tinè, F., Bertino, G., Giannitrapani, L., Benanti, F., Licata, A., Scalisi, I., Mazzola, G., Cartabellotta, F., Alessi, N., Barbàra, M., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V., Cammà, C., Craxì, A., Di Marco, V., Cammà, C., Calvaruso, V., Petta, S., Colletti, P., Mazzola, G., Licata, A., Giannitrapani, L., Corrao, S., Prestileo, T., Di Lorenzo, F., Fecarotta, R., Sanfilippo, P., Madonia, S., Tinè, F., Malizia, G., Latteri, F., Maida, M., Cartabellotta, F., Vassallo, R., Cacciola, I., Caccamo, G., Maimone, S., Saitta, C., Squadrito, G., Raimondo, G., Mondello, L., Smedile, A., Bertino, G., Ardiri, A.L., Montineri, A., Larocca, L. N., Cacopardo, B., Benanti, F., Russello, M., Benigno, R., Cannavò, M. R., Bellia, A., Iacobello, C., Davì, A., Di Rosolini, M. A., Digiacomo, A., Fuduli, G., Scifo, G., Distefano, M., Portelli, V., Savalli, F., Scalici, I., Gioia, G., Magro, A., Alaimo, G., Salvo, A., Averna, A., Lomonaco, F., Quattrocchi, U., Guarneri, L., Maffeo, F.

“…Summary Background Data on HCV‐related hepatocellular carcinoma (HCC) early recurrence in patients whose HCC was previously cured, and subsequently treated by…”
Get full text

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome by Marziali, G., Signore, M., Buccarelli, M., Grande, S., Palma, A., Biffoni, M., Rosi, A., D’Alessandris, Q.G., Martini, M., Larocca, L. M., De Maria, R., Pallini, R., Ricci-Vitiani, L.

“…Glioblastoma (GBM) is one of the deadliest human cancers. Because of the extremely unfavorable prognosis of GBM, it is important to develop more effective…”
Get full text

Chemotherapy resistance of glioblastoma stem cells by Eramo, A, Ricci-Vitiani, L, Zeuner, A, Pallini, R, Lotti, F, Sette, G, Pilozzi, E, Larocca, L M, Peschle, C, De Maria, R

Get full text

Greenland-wide accelerated retreat of peripheral glaciers in the twenty-first century by Larocca, L. J., Twining–Ward, M., Axford, Y., Schweinsberg, A. D., Larsen, S. H., Westergaard–Nielsen, A., Luetzenburg, G., Briner, J. P., Kjeldsen, K. K., Bjørk, A. A.

“…The long-term response of Greenland’s peripheral glaciers to climate change is widely undocumented. Here we use historical aerial photographs and satellite…”
Get full text

Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result by Pierconti, Francesco, Rossi, E D, Fiorentino, V, Bakacs, A, Carlino, A, Navarra, E, Sacco, E, Totaro, A, Palermo, G, Larocca, L M, Martini, M

“…Numerous studies showed that methylation analysis represents a newly developed urinary marker based on DNA methylation changes in a panel of genomic biomarkers…”
Get full text

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation by Calegari, M A, Inno, A, Monterisi, S, Orlandi, A, Santini, D, Basso, M, Cassano, A, Martini, M, Cenci, T, de Pascalis, I, Camarda, F, Barbaro, B, Larocca, L M, Gori, S, Tonini, G, Barone, C

“…Background: Presently, few options are available for refractory colorectal cancer (CRC). O6-methyl-guanine-DNA-methyltransferase ( MGMT ) promoter methylation…”
Get full text

Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas by Hohaus, S., Giachelia, M., Massini, G., Mansueto, G., Vannata, B., Bozzoli, V., Criscuolo, M., D'Alò, F., Martini, M., Larocca, L.M., Voso, M.T., Leone, G.

“…Levels of cell-free circulating DNA have been correlated to clinical characteristics and prognosis in patients with cancers of epithelial origin, while there…”
Get full text

A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells by Tate, C M, Pallini, R, Ricci-Vitiani, L, Dowless, M, Shiyanova, T, D'Alessandris, G Q, Morgante, L, Giannetti, S, Larocca, L M, di Martino, S, Rowlinson, S W, De Maria, R, Stancato, L

“…Glioblastoma multiforme (GBM) is among the most aggressive tumor types and is essentially an incurable malignancy characterized by resistance to chemo-,…”
Get full text

KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients by Basso, M, Strippoli, A, Orlandi, A, Martini, M, Calegari, M A, Schinzari, G, Di Salvatore, M, Cenci, T, Cassano, A, Larocca, L M, Barone, C

“…Background: In this study, we evaluated the possibility that KRAS mutational status might be predictive of oxaliplatin (OXA) efficacy. We also explored the…”
Get full text

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas by Ciceroni, C, Bonelli, M, Mastrantoni, E, Niccolini, C, Laurenza, M, Larocca, L M, Pallini, R, Traficante, A, Spinsanti, P, Ricci-Vitiani, L, Arcella, A, De Maria, R, Nicoletti, F, Battaglia, G, Melchiorri, D

“…Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSCs) to chemotherapy. GSCs isolated from human glioblastoma…”
Get full text

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo by Signore, M, Pelacchi, F, di Martino, S, Runci, D, Biffoni, M, Giannetti, S, Morgante, L, De Majo, M, Petricoin, E F, Stancato, L, Larocca, L M, De Maria, R, Pallini, R, Ricci-Vitiani, L

“…Glioblastoma (GBM) is the most common and deadly adult brain tumor. Despite aggressive surgery, radiation, and chemotherapy, the life expectancy of patients…”
Get full text

Stratifying the Risk of Hepatocellular Carcinoma in Cirrhotic Patients Using Liver Stiffness Measurement by Fibroscan - A Multicentre Study by Adler, M, Larocca, L, Trovato, F, Marcinkowski, H, Pasha, Y, Taylor-Robinson, S

Get full text

Mesenchymal differentiation of glioblastoma stem cells by Ricci-Vitiani, L, Pallini, R, Larocca, L M, Lombardi, D G, Signore, M, Pierconti, F, Petrucci, G, Montano, N, Maira, G, De Maria, R

“…Glioblastoma multiforme is a severe form of cancer most likely arising from the transformation of stem or progenitor cells resident in the brain. Although the…”
Get full text

Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules by Rossi, E. D., Martini, M., Capodimonti, S., Cenci, T., Bilotta, M., Pierconti, F., Pontecorvi, A., Lombardi, C. P., Fadda, G., Larocca, L. M.

“…Introduction Several authors have underlined the limits of morphological analysis mostly in the diagnosis of follicular neoplasms (FN). The application of…”
Get full text

Clinical utility of circulating tumor DNA qualification and quantification in classical Hodgkin lymphoma by Pirosa, M. C., Bruscaggin, A., Terzi di Bergamo, L., Salehi, M., Spina, V., Pini, K., Bocchetta, S., Giordano, C., Forestieri, G., Condoluci, A., Piffaretti, D., Almeida, J. Marques, Galimberti, G. A., Annunziata, S., Bergesio, F., Boldorini, R., Borsatti, E., Bulian, P., Chauvie, S., Cuzzocrea, M., di Trani, M., Cristaldi, V., Gerber, B., Jauk, F., Kurlapski, M., Larocca, L. M., Moccia, A., Moia, R., Rinaldi, A., Rodari, M., Romanowicz, G., Sacchetti, G. M., Stathis, A., Stüssi, G., Zangrilli, I., Pinto, A., Mazzucchelli, L., Gattei, V., Zaucha, J. M., Hohaus, S., Santoro, A., Carlo‐Stella, C., Gaidano, G., Cavalli, F., Zucca, E., Ceriani, L., Rossi, D.

Get full text

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma by Hohaus, S, Giachelia, M, Di Febo, A, Martini, M, Massini, G, Vannata, B, D'Alo', F, Guidi, F, Greco, M, Pierconti, F, Larocca, LM, Voso, MT, Leone, G

“…Background: In Hodgkin's lymphoma (HL), the production of cytokines by Reed–Sternberg cells and the surrounding tissue is thought to contribute to the biology…”
Get full text

Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse by Orlandi, A., Calegari, M. A., Martini, M., Cocomazzi, A., Bagalà, C., Indellicati, G., Zurlo, V., Basso, M., Cassano, A., Larocca, L. M., Barone, C.

“…Purpose hENT1 is a transmembrane protein which acts as a nucleoside transporter and is the main mediator of Gemcitabine (GEM) uptake into human cells. In this…”
Get full text

Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma by Bisegna, C., Gravina, G. L., Pierconti, F., Martini, M., Larocca, L., Rossi, P., Grimaldi, P., Dolci, S., Di Stasi, S., Jannini, E. A.

“…Background Type 5 phosphodiesterase (PDE5) expression in the normal and pathological prostate is controversial. Objectives This study aimed at identifying the…”
Get full text

The potential of liquid-based cytology in lymph node cytological evaluation: the role of morphology and the aid of ancillary techniques by Rossi, E. D., Martini, M., Straccia, P., Bizzarro, T., Fadda, G., Larocca, L. M.

“…Objectives Our aim was to evaluate the feasibility and diagnostic accuracy of liquid‐based cytology (LBC) on lymph node fine needle aspiration (FNA). FNA may…”
Get full text